Christopher J. DiMaio, MD, FASGE, from the Icahn School of Medicine at Mount Sinai, Mount Sinai Medical Center, in New York, New York, USA discusses his article "Pancreatic cyst fluid concentration of high-mobility group A2 protein acts as a differential biomarker of dysplasia in intraductal papillary mucinous neoplasm." No reliable cyst fluid biomarkers exist that …
Continue reading HMGA2 protein as a biomarker of dysplasia in IPMN
Martha B. Pitman, MD, from the Department of Pathology, Massachusetts General Hospital, Harvard Medical School, in Boston, Massachusetts, USA discusses this Original Article "Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts." This study assesses the impact of testing pancreatic cyst fluid for genetic mutations on the clinical impression of cyst etiology based …
Continue reading Next-generation sequencing and the clinical diagnosis of pancreatic cysts
endoscopedia.com 